These are diseases for which stem cell treatments have not been proven to have any efficacy in human beings. In a "Phase I" clinical trial, the purpose of the study is to find out if the therapy makes any difference in the course of the disease, as compared to a control group. Some doctors may also be giving stem cells to patients in experiments outside of clinical trials, but in the United States such experiments are subject to limitations imposed by FDA regulations.


Auto-Immune Diseases

Ø   Arthritis, Juvenile

Ø   Arthritis, Rheumatoid

Ø   Crohn's Disease

Ø   Diabetes, Type I

Ø   Evan Syndrome

Ø   Juvenile Dermatomyositis

Ø   Scleroderma

Ø   Lupus

Nerve cell repair

Diseases of the Central Nervous System

Amyotrophic Lateral Sclerosis 
(ALS, or "Lou Gehrig's disease")

Ø   Alzheimer's Disease

Ø   Huntington's Disease

Ø   Parkinson's Disease


Traumatic injury

Ø   Spinal cord injury

Ø   Stroke recovery


Gene Therapy 
(ie: Transplanting genetically altered stem cells)

Ø   Fanconi's Anemia

Ø   Metabolic Disorders (Leukodystrophy Diseases, Storage Disorders, etc.)

Ø   Parkinson's Disease

Organ repair


Ø   Combined transplant of kidney plus hematopoietic stem cells

Ø   Growth of renal cells from hematopoietic stem cells



Ø   Growth of liver cells from hematopoietic stem cells